Hong Kong · Delayed Price · Currency is HKD Sirnaomics Statistics
Total Valuation
Sirnaomics has a market cap or net worth of HKD 712.20 million. The enterprise value is 566.01 million.
| Market Cap | 712.20M |
| Enterprise Value | 566.01M |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Sirnaomics has 108.90 million shares outstanding. The number of shares has increased by 21.93% in one year.
| Current Share Class | 108.90M |
| Shares Outstanding | 108.90M |
| Shares Change (YoY) | +21.93% |
| Shares Change (QoQ) | +1.64% |
| Owned by Insiders (%) | 20.31% |
| Owned by Institutions (%) | n/a |
| Float | 82.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -3.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.05 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40
| Current Ratio | 0.40 |
| Quick Ratio | 0.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -37.81% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 84.25% |
| Weighted Average Cost of Capital (WACC) | 4.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.16M |
| Employee Count | 52 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +86.33% in the last 52 weeks. The beta is -0.09, so Sirnaomics's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | +86.33% |
| 50-Day Moving Average | 7.00 |
| 200-Day Moving Average | 8.94 |
| Relative Strength Index (RSI) | 52.49 |
| Average Volume (20 Days) | 187,060 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -115.21M |
| Pretax Income | -113.68M |
| Net Income | -112.10M |
| EBITDA | -101.98M |
| EBIT | -115.21M |
| Earnings Per Share (EPS) | -1.19 |
Balance Sheet
The company has 105.22 million in cash and 72.49 million in debt, with a net cash position of 32.72 million or 0.30 per share.
| Cash & Cash Equivalents | 105.22M |
| Total Debt | 72.49M |
| Net Cash | 32.72M |
| Net Cash Per Share | 0.30 |
| Equity (Book Value) | -190.63M |
| Book Value Per Share | -0.73 |
| Working Capital | -177.28M |
Cash Flow
| Operating Cash Flow | -71.58M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 13.32M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Sirnaomics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -21.93% |
| Shareholder Yield | -21.93% |
| Earnings Yield | -15.74% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |